The 23rd International Congress on Therapeutic Drug Monitoring and Clinical Toxicology (IATDMCT 2025) will be held in Singapore from September 21-24, 2025. The conference is organized by the International Association of Therapeutic Drug Monitoring and Clinical Toxicology (IATDMCT). The IATDMCT Congress will bring together world-class scientists and healthcare professionals engaged in therapeutic drug monitoring and clinical toxicology, providing researchers and clinicians with an opportunity to share their research and experiences in basic, clinical, and translational pharmacology and clinical toxicology. Attendees include: pharmaceutical analysts, clinical pharmacologists, clinical toxicologists, physicians, pharmacists, laboratory chemists, and others.
Diagreat Bio will also be exhibiting at Booth No. 2. We warmly welcome all experts and colleagues to visit our booth.
Our booth is located at Booth No. 2, and we sincerely invite you to visit us. Since its establishment, Diagreat Bio has consistently adhered to the core development philosophy of “Innovation, Pragmatism, and Mutual Benefit,” deeply cultivating the medical technology R&D sector. Leveraging profound insights into clinical needs and technological breakthroughs, we continuously introduce solutions that better align with clinical scenarios and demonstrate greater technological leadership, dedicated to injecting new momentum into the health and well-being of patients worldwide.
At this conference, Diagreat Bio will unveil two major new products for the first time, offering fresh perspectives on intelligent upgrades in the field of drug concentration monitoring:
1.Fully Automated Sample Pretreatment System for DrugConcentration Monitoring (DP120)
Revolutionizing sample processing workflows through automation technology, significantly enhancing testing efficiency and accuracy while minimizing manual error. Provides stable, high-efficiency pre-processing support for clinical diagnostics.
2.Model-Informed Drug Concentration Prediction System
Leveraging the MIPD concept of precision dosing guided by models, combined with big data and algorithmic advantages, it achieves accurate prediction of drug concentrations, supporting the development of personalized clinical dosing regimens.
We look forward to meeting you in person at Booth 2 to discuss industry trends, share technological achievements, and jointly advance the field of therapeutic drug monitoring and clinical toxicology. Diagreat Bio awaits your arrival!